Guangdong, China

Zhao Zhou

This inventor holds 4 USPTO granted patents. Top assignees: Guangzhou Bio-Gene Technology Co., Ltd, Guangzhou Bio-Gene Technology Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhao Zhou. Retrieved from https://idiyas.com/inventor/zhao-zhou-5gg4r6i4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 4.6

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Zhao Zhou

Introduction

Zhao Zhou is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies and therapeutic applications. With a total of 4 patents to his name, Zhao has established himself as a key figure in his area of expertise.

Latest Patents

Zhao Zhou's latest patents include groundbreaking work such as the "Anti-B7H3 Antibody and Use Thereof" and the "Chimeric Antigen Receptor Targeting CLL1 and Use Thereof." These inventions reflect his commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Throughout his career, Zhao has worked with notable companies, including Guangzhou Bio-Gene Technology Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts and contribute to significant advancements in biotechnology.

Collaborations

Zhao has collaborated with talented individuals such as Min Luo and Guangchao Li. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Zhao Zhou's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…